Old drugs, new tricks: Emerging role of drug repurposing in the management of atopic dermatitis.

Prasannanjaneyulu, Velpula; Nene, Shweta; Jain, Harsha; Nooreen, Rimsha; Otavi, Shivam; Chitlangya, Palak; Srivastava, Saurabh

Prasannanjaneyulu, Velpula; Nene, Shweta; Jain, Harsha; Nooreen, Rimsha; Otavi, Shivam; Chitlangya, Palak; Srivastava, Saurabh.

Afiliação

Prasannanjaneyulu V; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India.
Nene S; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India.
Jain H; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India.
Nooreen R; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India.
Otavi S; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India.
Chitlangya P; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India.
Srivastava S; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India. Electronic address: saurabh@niperhyd.ac.in.

Cytokine Growth Factor Rev ; 65: 12-26, 2022 06.

Article em En | MEDLINE | ID: mdl-35550114

Assuntos

Dermatite Atópica; Psoríase; Dermatite Atópica/tratamento farmacológico; Reposicionamento de Medicamentos; Humanos; Pele

Palavras-chave

Atopic dermatitis; Drug repurposing; Inflammation; JAK inhibitors; PDE-4 inhibitors; regulatory considerations

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Dermatite Atópica Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google